Daavlin Distributing Company recalls Phothera 200
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Some of the Calibration/Output Certificates had the outputs reversed.
- Products
-
- Phothera 200
- Company
- Daavlin Distributing Company
- Where it was sold
-
US Nationwide distribution.
Nationwide
- Units affected
- 368 units
- About this recall
- Phothera 200, Phototherapy Devices indicated for use to treat diagnosed skin disorders such as, but not limited to, Psoriasis, Vitiligo, and Atopic Dermatitis (Eczema) under the direction of a physician, Model Numbers 210NDT4 and 210NCL4